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Abstract The involvement of trigeminovascular afferent
nerves in the pathomechanism of primary headaches is well
established, but a pivotal role of a particular class of primary
sensory neurons has not been advocated. This review focus-
es on the evidence that supports the critical involvement of
transient receptor potential (TRP) channels in the patho-
physiology of primary headaches, in particular, migraine.
Transient receptor potential vanilloid 1 and transient recep-
tor potential ankyrin 1 receptors sensitive to vanilloids and
other irritants are localized on chemosensitive afferent
nerves, and they are involved in meningeal nociceptive
and vascular responses involving neurogenic dural vasodi-
latation and plasma extravasation. The concept of the tri-
geminal nocisensor complex is put forward which involves
the trigeminal chemosensitive afferent fibers/neurons
equipped with specific nocisensor molecules, the elements
of the meningeal microcirculatory system, and the dural
mast cells. It is suggested that the activation level of this
complex may explain some of the specific features of mi-
graine headache. Pharmacological modulation of TRP chan-
nel function may offer a novel approach to the management
of head pain, in particular, migraine.
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Introduction
Headaches, in particular, migraine, belongs to the most
frequent pains for which patients seek medical attention.
The mechanisms of migraine headaches are still incomplete-
ly understood, but they involve both neurogenic and vascu-
lar pathologies of the meninges. Theories focusing either on
the vascular or central and peripheral neuronal processes
have been evolved which could explain some but not all
fundamental aspects of this pain disorder. The functional
properties and electrophysiological traits of meningeal pri-
mary afferents have also been characterized in great detail,
but a pivotal role of a particular class of primary afferent
neurons has not been advocated. In recent years, the role of
transient receptor potential (TRP) channels in the patho-
physiology of different pain disorders has been well estab-
lished [11, 40, 98]. The existence and functional
significance of meningeal chemosensitive primary afferent
nerves, which are sensitive to vanilloids and other irritants
and express the transient receptor potential vanilloid 1
(TRPV1) and the transient receptor potential ankyrin 1
(TRPA1) receptors, are now well-documented [34, 96,
116]. Since in most organs and tissues of the body TRP
ion channels are intimately involved in the mediation of
noxious events [16, 26, 67, 73, 95], this review focuses on
the evidence that support the critical involvement of TRPV1
and TRPA1 channels in the pathophysiology of primary
headaches, in particular, migraine.
Nerves and neuroreceptors of the dura mater encephali
Classical anatomical and functional studies have revealed
some of the most important aspects of headache mecha-
nisms. Investigations into the origin of intracranial pain
suggested that the dura mater encephali is the main, and
probably the only, pain-sensitive structure within the crani-
um [44, 106]. Topographical analysis of the localization of
“pain receptors” also disclosed that almost exclusively the
paravascular regions of the dura mater but not areas remote
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from the larger blood vessels are sensitive to painful stimu-
lation [102]. Anatomical studies demonstrated the distribu-
tion of sympathetic and trigeminal sensory nerves within the
dura mater of several mammalian species, including man [2,
46, 70, 91, 92]. The dura mater is densely innervated by
both sympathetic and sensory nerves, which run freely in the
dural stroma or are clearly associated with meningeal arter-
ies and veins. Chemical neuroanatomical studies disclosed
the various populations of meningeal nerves containing
classical transmitters such as noradrenaline and the peptides
substance P (SP), neurokinin A (NKA), and calcitonin gene-
related peptide (CGRP) [18, 38, 125]. Most of these medi-
ators are contained in unmyelinated axons, but electron
microscopy revealed large numbers of myelinated nerve
fibers, too [2]. Electrophysiological studies have revealed
specific populations of dural sensory nerve fibers, many of
which showed response properties characteristic of nocicep-
tive afferents [120]. The majority of these nociceptive affer-
ents responded to noxious mechanical stimuli but also to
chemical agents, such as capsaicin [119, 121]. Sensitivity to
capsaicin is a fundamental feature of nociceptive afferent
fibers, which express the archetypical nociceptive ion chan-
nel, the TRPV1 receptor [17, 59, 61]. The existence of
unmyelinated capsaicin-sensitive afferent nerves in the rat
dura mater has been also demonstrated in electron micro-
scopic studies utilizing an experimental neuroanatomical
technique making use of the selective neurotoxic action of
capsaicin [34, 72]. Retrograde labelling combined with im-
munohistochemistry demonstrated many TRPV1-
immunoreactive trigeminal ganglion neurons that innervate
the dura mater [116]. In addition, immunohistochemical
findings furnished direct evidence for a dense innervation
of the rat dura mater by TRPV1-immunoreactive paravas-
cular and stromal nerve fibers [36]. Immunohistochemical
studies have further characterized the chemical phenotypes
of dural afferent fibers and revealed a subpopulation of
TRPV1-immunoreactive nerves, which also showed
proteinase-activated receptor-2 (PAR-2)-immunoreactivity.
Dural mast cells localized, in part, in the close vicinity of
blood vessels and also of afferent nerves displayed strong
PAR-2-immunoreactivity, too [36, 128]. Recently, another
member of the TRP receptor superfamily, the TRPA1, has
also been found to be functional on trigeminal dural afferent
nerves [76, 96]. The available experimental evidence sug-
gests that TRPA1 receptors are expressed in chemosensitive
primary afferent neurons that are peptidergic and also ex-
press the TRPV1 receptor [62, 66, 76, 118].
Although most studies dealing with headache mecha-
nisms in the context of neurogenic inflammation considered
the involvement of peptidergic primary afferent neurons
which express the TRPV1 receptor, it should be emphasized
that a large population of TRPV1-expressing neurons are
not peptidergic [19, 105]. Non-peptidergic nociceptive
primary sensory neurons may be identified through their
binding of the plant lectin, Griffonia simplicifolia isolectin
B4 (IB4). The possible significance of non-peptidergic no-
ciceptive afferents as regards the pathomechanism of head-
aches has been rarely addressed. It is conceivable that these
non-peptidergic TRPV1-expressing nerves do not contribute
to local neurogenic vascular reactions, but they provide a
parallel afferent pathway for the transmission of nociceptive
signals. Although available evidence indicates that the IB4-
positive and the IB4-negative subpopulations of TRPV1-
expressing sensory ganglion neurons also show distinct
functional characteristics [82, 113], especially under inflam-
matory conditions [12, 49], the significance of a possible
parallel processing of dural nociceptive information remains
to be elucidated.
The concept of the trigeminovascular nocisensor
complex
The exact mechanisms of the generation of primary head-
aches like migraine are still unclear, but apparently, they
involve both neurogenic and vascular events. Whereas cor-
tical spreading depression is believed to play an important
role in the development of migraine aura [78, 115, 129], the
pathophysiological changes in the trigeminovascular system
are considered to be of fundamental importance in the
generation and maintenance of headache pain. Dysfunctions
of the peripheral and/or the central components of the tri-
geminal nociceptive pathway may be responsible for the
generation of intracranial pain and changes in blood flow
in headache patients [5, 10, 13, 20, 90]. Many, but not all,
trigeminovascular afferents contain vasoactive peptides,
such as SP and CGRP. These peptides contained in primary
sensory neurons serve not only as transmitters at the central
synapses of nociceptive afferents [32, 56, 79], but they also
play a pivotal role in the mechanisms of the neurogenic
inflammatory response originally described in exteroceptive
innervation territories (for reviews, see [23, 64, 87]). This
unique neurovascular reaction has two components, neuro-
genic vasodilatation mediated through CGRP and neurogen-
ic plasma extravasation mediated by SP. Neurogenic
inflammation is a sterile inflammatory reaction brought
about by the release of CGRP, SP, and probably NKA from
sensory nerve endings as a consequence of antidromic or
orthodromic stimulation of nociceptive afferent nerves [42,
48, 60, 61, 103, 112]. The biological significance of neuro-
genic inflammation is somewhat obscure and may differ in
different organ systems and tissues, but a protective role of
sensory neurogenic vasodilatation seems obvious [6]. An
increase of blood flow in tissues flooded with microbial
products and/or inflammatory mediators may promote the
removal of noxious agents and help to restore tissue
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homeostasis. Tissue reactions related to neurogenic inflam-
mation have been shown to aggravate or attenuate tissue
injury [31, 41, 50, 63, 64, 68]. In the dura mater, induction
of a neurogenic inflammatory response through electrical
stimulation of chemosensitive trigeminal afferents has been
shown to produce an increase in vascular permeability that
could be prevented by depletion of chemosensitive afferents
and/or sensory neuropeptides by prior capsaicin desensiti-
zation [14]. The significance of neurogenic plasma extrav-
asation as regards migraine pathogenesis in humans is
controversial [127]. Clinical studies suggested that a mi-
graine attack can neither be alleviated nor prevented by
neurokinin antagonists. Hence, neurogenic plasma extrava-
sation was suggested to be of minor significance as a path-
ogenetic factor of migraine [29], although more recent
studies have demonstrated an increase in meningeal blood
vessel permeability during migraine aura in humans [57]. In
contrast, neurogenic sensory vasodilatation mediated also
by peptide, in particular CGRP, release from chemosensitive
afferents appears to play an important role in the pathome-
chanism of migraine. Its release into the jugular blood has
been demonstrated during migraine attacks in humans [52],
and, importantly, non-peptide CGRP antagonists have been
shown to alleviate migraine headache [39, 101, 110].
Animal models of intracranial pain and headaches have
also provided valuable data on the mechanisms of menin-
geal sensory neurogenic vasodilatation. Electrical stimula-
tion of meningeal nerves produces vasodilatation in dural
blood vessels, which is mediated by the release of CGRP
from sensory nerves [77]. This was supported by the find-
ings that both peptide and non-peptide CGRP antagonists
inhibited meningeal neurogenic vasodilatation [94, 122].
Prior treatment of the animals with capsaicin greatly re-
duced or even completely abolished dural neurogenic vaso-
dilatation due to the depletion of sensory neuropeptides and/
or afferent nerves [34, 35]. Importantly, capsaicin, the ar-
chetypical TRPV1 agonist also evoked an increase in men-
ingeal blood flow after local application in a rat open cranial
window model of migraine headache. This vasodilatory
response was abolished through prior capsaicin desensitiza-
tion and by capsazepine, a TRPV1 antagonist [34]. These
findings indicated that meningeal neurogenic vasodilatation
is mediated through the activation of chemosensitive affer-
ent nerves, which are sensitive to capsaicin and express the
TRPV1 ion channel. The involvement of this particular class
of sensory nerves in meningeal neurogenic plasma extrava-
sation and activation of trigeminovascular nociceptive affer-
ents is also well established [89]. Hence, activation of
second-order neurons of the trigeminal nucleus caudalis by
meningeal application of capsaicin or other chemical agents
was inhibited after neonatal or systemic administration of
capsaicin as assessed with the c-fos technique [99]. Electron
microscopic and immunohistochemical data furnished direct
evidence for the existence and distribution of unmyelinated
capsaicin-sensitive TRPV1 immunoreactive sensory nerve
fibers in the rat dura mater [34–36, 116]. Investigations into
the significance of chemosensitive afferent nerves in men-
ingeal vascular reactions have also revealed that at least a
subpopulation of these particular afferents express the PAR-
2 receptor, the activation of which elicits vasodilatation [36].
PAR-2 activation-induced vasodilatation is mediated by
CGRP and a pathway involving nitric oxide [36, 37]. The
activation of PAR-2 receptors localized on meningeal che-
mosensitive afferent nerves may be brought about by pro-
teolytic enzymes, e.g., by tryptase released from activated
mast cells. Activation of mast cells has been shown after
electrical or chemical stimulation of dural afferent nerves,
and it is believed to modulate the neurogenic inflammatory
response [30]. This assumption is supported by the findings,
which demonstrated that activation of PAR-2 induced sen-
sitization of the TRPV1 receptor [36]. These observations
suggest that PAR-2-mediated activation and sensitization of
meningeal chemosensitive C-fiber nociceptors may signifi-
cantly contribute to the pathophysiology of headaches.
Considering the possible mechanisms that may operate to
maintain headache pain, a complex interplay among the differ-
ent pain-producing agents implicated in meningeal nociception
should be taken into account. Stimulation of chemosensitive
afferent nerves, e.g., through activation of the TRPV1 receptors
by inflammatory mediators, such as bradykinin, prostanoids,
endovanilloids, and low pH, characteristic of inflammatory
exudates, induces a CGRP-mediated marked increase in men-
ingeal blood flow locally and activation of second order neu-
rons in the caudal trigeminal nucleus centrally [80]. Similarly,
activation of the TRPA1 receptors by, e.g., environmental
irritants results in the release of CGRP from the dura mater
and may also produce head pain [76, 96]. The activation of
meningeal chemosensitive afferents also leads to the release of
vasoactive tachykinins, SP, and NKA, which may elicit an
increase in vascular permeability and moderate vasodilatation,
too. Tachykinins and CGRP may affect meningeal mast cells
resulting in the release of mast cell constituents and mediators,
such as histamine and the proteolytic enzyme, tryptase [65, 81].
These, in turn, may further activate meningeal chemosensitive
nociceptors resulting in additional neuropeptide release and
central activation. Moreover, activation of neuronal PAR-2
receptors produces sensitization of the TRPV1 receptor [36],
resulting in a further increase in dural blood flow. At present, it
is unclear whether axon reflex mechanisms are involved in
meningeal nociceptive functions, but previous findings have
suggested the participation of sensory axon collaterals in neu-
rogenic inflammatory responses in other somatic and visceral
organs [3, 33, 84, 108] (Fig. 1).
The events, which follow the activation of dural chemo-
sensitive nocisensors, may be regarded as components of a
positive feedback regulation, which may generate an
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exaggeration of the initial nociceptive and vascular responses.
This assumption is in line with clinical observations showing a
significant worsening of the initial symptoms in the course of a
migraine attack. The mechanisms leading to the initiation of
the migraine attack are, at present, as enigmatic as the mech-
anisms operating at the cessation of the headache pain.
Considering the available experimental evidence, a con-
cept of a trigeminovascular nocisensor complex is proposed.
It is further suggested that the peripheral mechanisms par-
ticipating in the initiation, maintenance, and cessation of
head pain may be explained in the frame of this concept.
The elements of this complex include the trigeminovascu-
lar chemosensitive primary afferent neuron with its peripheral
and central processes, the meningeal vascular bed, and the
dural mast cells. It is suggested that the elements of this
complex are both anatomically and functionally intimately
interconnected and may be regarded as an important physio-
logical and pathophysiological entity. Morphological studies
furnished evidence for the close association of meningeal
sensory nerves with blood vessels and also with mast cells
[46]. Activation and sensitization of meningeal nociceptors by
a variety of blood- and tissue-born inflammatory agents is the
most important peripheral mechanism in the initiation of a
migraine attack [51]. Some of these agents may act on their
specific receptors expressed on nociceptors, whereas others
may activate the TRPV1 and TRPA1 ion channels. The bio-
chemical pathways for the activation of these specific noci-
ceptive channels are now well established [93].
The activated nociceptor nerves transmit nociceptive
impulses toward the central nervous system, and they also
release vasoactive peptides, which exert their effect on neigh-
boring blood vessels. CGRP causes vasodilatation whereas SP/
Fig. 1 Functions of the trigeminovascular nocisensor complex. The
dural chemosensitive afferent nerves equipped with specific nocisensor
molecules, in particular, TRP channels, the elements of the meningeal
microcirculatory system, and the dural mast cells comprise the compo-
nents of the trigeminovascular nocisensor complex. Stimulation of
dural nociceptors by noxious agents results in the parallel transmission
of nociceptive signals toward the central nervous system through
peptidergic and non-peptidergic (IB4-positive) primary sensory neu-
rons. Importantly, peptidergic nerves also release the vasoactive pep-
tides CGRP and SP if stimulated, which produce vasodilatation and
plasma extravasation, respectively. Stimulated nociceptors may also
activate other nociceptive endings through an axon reflex mechanism
(curved arrow). A variety of tissue mediators may excite or sensitize
the TRP channels, which may also be sensitized through the activation
of PAR-2 receptors by mast cell tryptase. Mast cells may be activated
by CGRP and SP released from the nociceptor terminals and also by
mast cell tryptase. Available evidence suggests a mutual activation of
mast cells through the PAR-2 receptor, which provides a possibility for
a self-triggering mechanism of mast cells resulting in an augmentation
of the primary response. For further details, see text. BK bradykinin,
CGRP calcitonin gene-related peptide, 5-HT serotonin, IB4 G. simpli-
cifolia isolectin B4, NKA neurokinin A, PAR-2 proteinase-activated
receptor-2, PGE2 prostaglandin E2, SP substance P, TRPA1 transient
receptor potential ankyrin 1, TRPV1 transient receptor potential vanil-
loid 1, NGF nerve growth factor, H histamine, CNS central nervous
system
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NKA may cause an increase in vascular (mainly postcapillary
venular) permeability, i.e., a neurogenic inflammatory re-
sponse [24, 114]. In addition, these vasoactive peptides also
induce mast cell activation resulting in the release of mast cell
mediators, such as histamine and mast cell tryptase [30].
These, in turn, may activate receptors of the nociceptive nerve
terminals resulting in further neuropeptide release that strongly
amplifies the initial vascular reaction and possibly also the
central transmission of the nociceptive signal. The primary
reaction is further augmented through the sensitization of
nociceptors by inflammatory mediators, including nerve
growth factor, and also by the activation of PAR-2 receptors.
Sensitization of meningeal nociceptors through the activation
of PAR-2 receptors co-expressed with the TRPV1 receptors in
chemosensitive afferents has been revealed recently [36]. This
observation is particularly interesting in the light of a self-
amplification mechanism of mast cell degranulation through
which mast cells may amplify their own activation–degranu-
lation signals in an autocrine or paracrine manner [55]. The
available data of human studies and animal experiments sug-
gest that many facets of the peripheral pathomechanisms of
head pain may be explained in the frame of the proposed
concept of the trigeminovascular nocisensor complex. The
elements of this system function in a concerted manner to
initiate and to maintain and augment the vascular and nocicep-
tive responses associated with migraine headaches, e.g.,
through blood, tissue, and nociceptor-born inflammatory
mediators, and through nocisensor sensitization and mast cell
(auto)activation, respectively. TRPV1 and TRPA1 receptors
expressed by chemosensitive afferent neurons play a pivotal
role in the functioning of the trigeminovascular nocisensor
complex through both the central transmission of nociceptive
signals and the peripheral release of vasoactive neuropeptides
synthesized and transported in a peripherally regulated manner
to their endings in the dura mater. Considering the changes in
the levels of CGRP in the jugular blood of humans during
migraine headache [52] and the decreased dural CGRP levels
after prolonged electrical stimulation of trigeminal afferents
[74, 111], it is tempting to suggest that depletion of the peptide
from dural afferent nerves and the consequent decreased acti-
vation level of the trigeminovascular nocisensor complex may
be related to the cessation of head pain. In addition, neurogenic
sensory vasodilatation may have also beneficial effects by
removing tissue metabolites inducing or aggravating headache
attacks [34, 35, 37].
Inhaled environmental irritants induce headache
through the activation of TRPA1
The TRPA1 ion channel, another member of the TRP re-
ceptor superfamily, has emerged recently as possibly the
most important receptor activated by noxious chemical
agents including environmental irritants [7]. The expression
of TRPA1 has been also demonstrated in a population of
trigeminal nociceptive neurons [71]. TRPA1 receptors can
be activated by noxious cold, different environmental elec-
trophyl irritants like acrolein and formaldehyde and also by
pungent ingredients of plant origin, like cinnamaldehyde
and allyl isothiocyanate [4, 66, 85, 123]. Hydrogen perox-
ide, 4-hydroxylnonenal, and a prostaglandin metabolite pro-
duced endogenously in sensory ganglion cells excite the
TRPA1 receptor [15, 25]. Both exogenous and endogenous
activators of the TRPA1 modify cysteine residues of the
receptor by the formation of either covalent or not covalent
bonds [86, 126]. In susceptible persons asthma, allergic
rhinitis, and headache attacks are well-known consequences
of exposure to environmental irritants. Recent findings fur-
nished direct evidence for the involvement of TRPA1 recep-
tors in headache mechanisms in humans by showing that
umbellulone, the major volatile constituent of the “headache
tree”, Umbellularia californica, provokes headaches
through the activation of the TRPA1 receptor [96]. Similarly
to TRPV1, activation of trigeminovascular afferents through
TRPA1 receptors causes nociceptive responses and the re-
lease of CGRP in rodents. Both nociceptive responses and
CGRP release were absent in TRPA1-deficient mice [100].
It has been suggested that a number of irritant agents such as
chlorine, cigarette smoke, and formaldehyde triggers head
pain through the activation of the TRPA1 channel [1, 8, 47,
88]. This suggestion is supported by immunohistochemical
and in situ hybridization findings which revealed that 36%
of the trigeminal sensory ganglion neurons express TRPA1
in rodents. TRPA1 was present almost exclusively in small-
and medium-sized neurons. The overwhelming majority
(97 %) of TRPA1-expressing cells contained also the vaso-
active neuropeptides CGRP and SP [118]. Double immu-
nostaining of rat sensory ganglion cells revealed that 80% of
TRPA1 imunoreactive neurons also expressed the PAR-2
receptor [27]. This high percentage of coexpression provides
a firm morphological basis for the functional cooperation
between these receptors. Mast cell tryptase activating the
PAR-2 receptor may sensitize not only the TRPV1 but also
the TRPA1 receptors of trigeminal afferents. PAR-2-mediated
TRPA1 sensitization seems to activate an intracellular mech-
anism that is independent of the protein kinase C path-
way. Cleavage of PAR-2 may activate phopholipase C
which releases the inhibition of TRPA1 from membrane
phosphatidylinositol-4,5-bisphosphate [27].
Interactions of TRPV1 and TRPA1 receptors
in trigeminal sensory ganglion cells
Histological and functional observations have revealed the
co-localization of TRPV1 and TRPA1 receptors in both the
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dorsal root [66, 118] and the trigeminal [66, 109] sensory
ganglion neurons. Although the mechanisms of activation of
these channels differ significantly, experimental evidence
indicates a functional interaction between TRPV1 and
TRPA1 receptors which may modify the responses of noci-
ceptive neurons toward the selective chemical activators of
these ion channels. By recording mustard-oil-induced ionic
currents from Chinese hamster ovary cells co-transfected
with TRPA1/TRPV1 mRNAs or trigeminal ganglion neu-
rons isolated from TRPV1 knock-out animals, Salas and co-
workers [109] demonstrated that the amplitude, calcium sen-
sitivity, and voltage-dependency of the mustard-oil-induced
currents were strongly affected by the presence or absence of
the TRPV1 channel. A non-significant difference in the am-
plitude of the mustard-oil-induced membrane currents be-
tween the capsaicin-sensitive and capsaicin-insensitive
subpopulations of vagal afferent neurons was also reported
[21]. Since mustard oil does not produce a direct activation of
TRPV1 receptor at the concentration used in these experi-
ments [43], it was hypothesized that TRPV1 either stabilizes
the membrane localization of functional TRPA1 channels or
(positively) regulates their sensitivity toward the TRPA1-
specific chemical irritants [109]. Conversely, TRPA1 channel
activation has been shown to restore the capsaicin sensitivity
of TRPV1 following desensitization of the channel with re-
peated brief exposures to capsaicin [130]. Similar synergisms
between the TRPV1 and TRPA1 channels might also occur
centrally at the medullary termination sites of chemosensitive
dural afferents which co-express these TRP channels [54, 69,
123]. Crosstalk between TRP channels might bear of special
importance under conditions of receptor sensitization through
inflammatory mediators brought about, in part, by post-
translational modifications of the TRP channels [22, 58, 83,
124]. It has been demonstrated that, following sensitization of
the TRPV1 channel, the activation threshold for both thermal
and chemical stimuli decreases significantly, resulting in the
opening of the channel at physiological temperatures [45,
104]. Similarly, endogenous agonists which possess low po-
tency and/or are present at very low tissue concentrations may
also activate the sensitized channel [28, 117].
TRPV1 and TRPA1 receptors localized in trigeminal
afferents innervating extracranial tissues may contribute
to meningeal sensory neurogenic vascular reactions
and head pain
Under experimental conditions, capsaicin, mustard oil, and
acrolein through the activation of TRPV1 and/or TRPA1
receptors of the nasal mucosa induce meningeal vasodilata-
tion in the rat which is mediated by the release of CGRP
from trigeminal perivascular nerves. Although the contribu-
tion of a trigemino-parasympathetic reflex increasing
meningeal blood flow after noxious chemical stimulation
of the facial mucosa cannot be excluded [53], it is very
likely that trigeminal afferents that innervate the nasal mu-
cosa project collaterals to meningeal blood vessels. Noci-
ceptive stimulation of extracranial tissues may activate
intracranial collaterals by an axon reflex mechanism and
release vasoactive neuropeptides in the meningeal tissue.
In humans, inhaled irritants may stimulate such extracranial
trigeminal afferents that innervate the nasal mucosa and
project collaterals also to the meningeal blood vessels [76,
96]. In mice, immunohistochemistry has revealed CGRP-
immunoreactive sensory nerve fibres in the emissary canals
and sutures of cranial bones that were branches of dural
nerves [75]. Activation of such extracranial collaterals of
meningeal sensory vasomotor nerve fibers may explain the
induction of headache attacks by extracranial triggers, such
as tenderness of scalp muscles. The pathophysiological role
of the excitation of TRPV1 and TRPA1 receptors that are
localized on extracranial collaterals of meningeal trigeminal
afferents is further supported by the beneficial effect of
botulinum toxin injection into the pericranial muscles for
migraine prevention. Botulinum toxin inhibits the release of
CGRP, SP, and glutamate from the primary nociceptive
neurons, reducing the neurogenic inflammation in the dura
mater and the peripheral sensitization of the nociceptors [9,
97]. This may reduce the inflow of nociceptive information
to the central nervous system that may inhibit also the
central sensitization of neurons in the trigeminal nucleus
caudalis [107]. Clinical studies proved that injection of
botulinum toxin into pericranial muscles is an effective
treatment in the prophylaxis of migraine.
Concluding remarks
Clinical observations and animal studies provided evidence
for a central role of chemosensitive trigeminal afferents,
which express the nociceptor ion channels TRPV1 and
TRPA1, in the mechanisms of meningeal nociception and
headache. Trigeminal chemosensitive primary sensory neu-
rons are comprised of peptidergic and non-peptidergic pop-
ulations of different functional traits which may serve
parallel transmission of the nociceptive information towards
the central nervous system. It is suggested that many facets
of the peripheral mechanisms of head pain may be explained
in the frame of the proposed concept of the trigeminovas-
cular nocisensor complex. The elements of this system
function in a concerted manner to initiate and to maintain
and augment the vascular, inflammatory, and nociceptive
responses associated with migraine headaches, e.g., through
blood, tissue, and nociceptor-born inflammatory mediators,
and through nocisensor sensitization and mast cell
(auto)activation, respectively. TRPV1 and TRPA1 receptors
244 Pflugers Arch - Eur J Physiol (2012) 464:239–248
expressed by chemosensitive afferent neurons play a pivotal
role in the functioning of the trigeminovascular nocisensor
complex through both the central transmission of nocicep-
tive signals and peripheral release of vasoactive neuropep-
tides synthesized and transported in a peripherally regulated
manner to their endings in the dura mater. Pharmacological
and/or genetic manipulations which selectively eliminate
chemosensitive nociceptor afferent nerves and/or interfere
with the function of the TRP channels, TRPV1 and TRPA1,
may offer new approaches to the further understanding of
the pathophysiology of headaches and also for the manage-
ment of primary headaches, in particular, migraine.
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